Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers

K. E. Dooley, E. E. Bliven-Sizemore, M. Weiner, Y. Lu, E. L. Nuermberger, W. C. Hubbard, E. J. Fuchs, M. T. Melia, W. J. Burman, S. E. Dorman

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers'. Together they form a unique fingerprint.

Medicine & Life Sciences